MIFAMURTIDE 4MG POWDER FOR SUSPENSION FOR INFUSION
key details
| Status | complete |
|---|---|
| Region | Northern Ireland |
| Procedure | direct |
| OCID | ocds-h6vhtk-06b67e |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| ALLOGA UK LIMITED | £280,000 | 16 Jun 2026 | active |
description
Procurement of MIFAMURTIDE 4MG POWDER FOR SUSPENSION FOR INFUSION
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 17 Jun 2026 | Transparency notice (UK5) | Procurement Act 2023 | 056900-2026 |
| 17 Jun 2026 | Contract award (UK6) | Procurement Act 2023 | 056909-2026 |
| 7 Jul 2026 | Contract details (UK7) | Procurement Act 2023 | 063438-2026 |
more from Belfast Health & Social Care Trust
- RISDIPLAM 5MG TABLETS, 28 tablets, pack HOMECARE · £3,000,000 · 11 Sept 2026
- Maintenance of Ultima Equipment · £557,000 · 7 Sept 2026
- Maintenance of Merivaara Operating Lights · £246,160 · 7 Sept 2026
- SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack · £280,000 · 7 Sept 2026
- Nemolizumab 30MG PEN (HOMECARE) · £150,000 · 7 Sept 2026
- AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE) · £670,000 · 7 Sept 2026
- GIVINOSTAT 8.86MG/ML ORAL SUSPENSION SUGAR-FREE, 140 mL · £475,000 · 7 Sept 2026
- Maintenance of Trumpf and Mindray Surgical Equipment · £935,340 · 3 Sept 2026
all contracts from this buyer →
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.